Plain-English translation of NCT06873659 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This trial is testing a new cancer medication called that works in a different way than traditional chemotherapy. Instead of killing cancer cells, is designed to reprogram cancer cells and transform them back into normal, healthy cells. The study will enroll about 96 people with advanced solid tumors, including liver and gastric cancers, to see if this medication is safe and effective.
Standard cancer treatments like chemotherapy, radiation, and immunotherapy often have serious side effects and can stop working when cancer becomes resistant. This medication is being studied because it uses a completely new approach—converting cancer cells rather than destroying them—which researchers hope could work better for people whose cancers no longer respond to standard therapies.
You likely qualify if…
You likely don't qualify if…
You would receive the medication through an IV infusion lasting about 2.5 hours, once per week for up to 6 cycles (each cycle is 28 days). The study starts with lower doses and gradually increases them to find the safest and most effective dose. You would also need to have tumor biopsies (small tissue samples) taken before, during, and possibly after treatment so researchers can see if the medication is working. Throughout the study, you'll have regular blood tests and imaging scans to monitor your health and tumor response.
AI-generated summary from trial data · Jun 9, 2026 · Not medical advice
China